Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06940089 · ClinicalTrials.gov registry record · NA

Invasive Brain-Computer Interfaces for Attention

A NA study of Epilepsy and Epilepsy in Children, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06940089 is a NA study of Epilepsy and Epilepsy in Children that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 30 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06940089, a NA study of Epilepsy and Epilepsy in Children, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this interventional study is to compare if the use of a brain-machine interface (BCI) therapy can improve the symptoms of attentional deficit by producing brain changes in the networks that modulate attention. The investigators intend to work with epileptic participants who do not respond to pharmacological treatment, who will undergo neurosurgery. The questions the study sets out to answer are: 1. is there an improvement of symptoms in an experimental group receiving the treatment versus a sham group receiving a simulation of the treatment? 2. does the application of the therapy before surgery reduce the recovery times of post-surgery cognitive deficits described in the literature? Making use of the information recorded from brain electrodes implanted before a participant's epilepsy surgery, the investigators will create a BCI decoder that works with the available activity sources to establish the level of attention of each participant when performing tasks. Participants: * will perform an offline phase first, which will consist of one day of evaluation, in which they will be familiarized with an attentional task. * will perform a training phase later, which will consist of several days of evaluation, where they will learn to modulate their level of attention. This modulation will be facilitated by the BCI decoder, which will classify the level of attention directly from the brain and provide visual feedback that the participant will use as a guide. If the participant is part of the experimental group (or BCI group), the feedback will work as described and should be easy to follow, but if the participant is part of the Sham group, the feedback will not work according to the brain activity of the actual participant, but according to that of another person. Because of this, a mismatch will be created between the moments a brain experiences inattention, and participants believe they are experiencing inattention. This is a randomized, double-blind stud

Interventions

  • BEHAVIORAL Attention Intervention using a customized BCI decoder
  • BEHAVIORAL Attention Intervention without using a customized BCI decoder

Study Locations (1)

Texas

  • Dell Children's Medical Center - Austin

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-05-01
Est. Completion 2026-12-01
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT06940089

The ClinicalTrials.gov registry entry for NCT06940089 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Attention Intervention using a customized BCI decoder is the first listed.

NCT06940089 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06940089 about?

NCT06940089 is a clinical study titled "Invasive Brain-Computer Interfaces for Attention". The goal of this interventional study is to compare if the use of a brain-machine interface (BCI) therapy can improve the symptoms of attentional deficit by producing brain changes in the networks that modulate attention. The investigators intend to work with epileptic participants who do not respon...

What is the current status of trial NCT06940089?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-01. Estimated completion is 2026-12-01.

What conditions does trial NCT06940089 study?

This clinical trial studies the following conditions: Epilepsy, Epilepsy in Children.

What interventions are being tested in trial NCT06940089?

The interventions under investigation include: Attention Intervention using a customized BCI decoder (BEHAVIORAL), Attention Intervention without using a customized BCI decoder (BEHAVIORAL).

Who is sponsoring clinical trial NCT06940089?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06940089 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.